But turning this crisis into an opportunity is possible. To mitigate the effects of the funding freeze, Bekker said swift ...

Nearly half of all new cases in 2022 were in the South. "The frustrating part is we have the tools now to stop it." ...

Promising results from an early-stage trial suggest that lenacapavir injections might offer long-lasting protection.

Accurate and ethical journalism on HIV/AIDS plays a vital role in shaping public perceptions, encouraging behavioral change, and raising awareness. Misinformation or vague reporting, however, can ...

An annual shot to protect against HIV infection has successfully passed an early safety trial, according to research ...

In the general population, frailty is an aging-related risk factor for poor outcomes; individuals experiencing frailty face ...

During the opening day of the Conference on Retroviruses and Opportunistic Infections, Rebecca Denison, a decades-long HIV ...

PEPFAR, a global program to combat AIDS, faces an existential threat due to partisan politics, but Congress has an opportunity to reform the program and ensure its continued success.

The advent of effective antiretroviral therapy (ART) has increased the lifespan of many people living with HIV. As a result, ...

UCSF researchers are the first to confirm that this approach is effective for the patients who need it most. Patients who ...

Gilead released data showing that an HIV drug, called lenacapavir, could provide virtually complete protection against ...

The Conference on Retroviruses and Opportunistic Infections 2025 opened with a session dedicated to informing attendees about ...